Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.

Filippi M, D'Amico E, Brescia Morra V, Zanetta C, Zanghì A, Di Filippo P S, Longobardi E, Colombo E, Mirabella M, Conte A, et al.